Ketoconazole administration in hypercortisolemic depression

American Journal of Psychiatry

Volumn 150, Issue 5, 1993, Pages 810-812

  Wolkowitz, Owen M ^a   Reus, Victor I ^b   Manfredi, Francesca ^b   Ingbar, Jonathan ^b   Brizendine, Louann ^b   Weingartner, Herbert ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; KETOCONAZOLE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DRUG RESPONSE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

ADULT; AGED; DEPRESSION, CHEMICAL; DEPRESSIVE DISORDER; FEMALE; HUMAN; HYDROCORTISONE; KETOCONAZOLE; MALE; MIDDLE AGE; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027288543     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.150.5.810     Document Type: Article

References (16)

1. Starkman MN, Schteingart DE, Schork MA: Cushing's syndrome after treatment: changes in cortisol and ACTH levels and amelioration of the depressive syndrome. Psychiatry Res 1986; 19:177-188
2. Hall RC, Popkin MK, Stickney SK, Gardner ER: Presentation of the steroid psychoses. J Nerv Ment Dis 1979; 167:229-236
3. Ravaris CL, Sateia MJ, Beroza KW, Noordsy DL: Effect of ketoconazole on a hypophysectomized, hypercortisolemic, psychotically depressed woman. Arch Gen Psychiatry 1988; 45: 966-967
4. Murphy BEP, Dhar V, Ghadirian AM, Chouinard G, Keller R: Response to steroid suppression in major depression resistant to antidepressant therapy. J Clin Psychopharmacol 1991; 11:121-126
5. Camara EG: Cyproheptadine in major depression, in New Research Program and Abstracts, 144th Annual Meeting of the American Psychiatric Association. Washington, DC, APA, 1991
6. Schatzberg AF, Rothschild AJ, Langlais PJ, Bird ED, Cole JO: A corticosteroid/dopamine hypothesis of psychotic depression and related states. J Psychiatr Res 1985; 19:57-64
7. Wolkowitz OM, Reus VI, Weingartner H, Thompson K, Breier A, Doran A, Rubinow D, Pickar D: Cognitive effects of corticosteroids. Am J Psychiatry 1990; 147:1297-1303
8. Wolkowitz OM, Rubinow D, Doran AR, Breier A, Berrettini WH, Kling MA, Pickar D: Prednisone effects on neurochemistry and behavior. Arch Gen Psychiatry 1990; 47:963-968
9. Reus VI: Pituitary-adrenal disinhibition as the independent variable in the assessment of behavioral symptoms. Biol Psychiatry 1982; 17:317-325
10. Sonino N: The use of ketoconazole as an inhibitor of steroid production. N Engl J Med 1987; 317:812-818
11. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
12. Bunney WE, Hamburg DA: Methods for reliable longitudinal observation of behavior. Arch Gen Psychiatry 1963; 9:280-294
13. Beck A, Ward CH, Mendelson M, Mock J, Urbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961; 42: 667-675
14. Derogatis L, Lipman R, Covi L: SCL-90: an outpatient psychiat-ne rating scale: preliminary report. Psychopharmacol Bull 1973; 9:13-17
15. Deptula DJ: Lateralized brain dysfunction in depression: an analysis of memory. Dissertation Abstracts International 1983; 44(B):3189
16. Nieman LK, Chrousos GP, Kellner C, Spitz IM, Nisula BC, Cuttler GB, Merriam GR, Bardin CW, Loriaux DL: Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. J Clin Endocrinol Metab 1985; 61:536-540